Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
MARKER THERAPEUTICS, INC. (MRKR) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.23M |
|
$-2.00M |
|
-- |
|
$1.23M |
|
$3.37M |
|
$-2.14M |
|
$0.14M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.14M |
|
$-2.14M |
|
16.76M |
|
16.76M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$21.73M |
|
-- |
|
-- |
|
$21.73M |
|
$3.35M |
|
-- |
|
-- |
|
$3.35M |
|
$18.39M |
|
$18.39M |
|
$18.39M |
|
16.70M |
|
| Cash Flow Statement Financials | |
$-10.11M |
|
-- |
|
$9.86M |
|
$19.19M |
|
$18.94M |
|
$-0.25M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.50 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-173.30% |
|
-173.30% |
|
-- |
|
-162.11% |
|
-162.11% |
|
$-10.11M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
0.74 |
|
121.55 |
|
-10.87% |
|
-10.87% |
|
-9.20% |
|
-10.87% |
|
$1.10 |
|
$-0.60 |
|
$-0.60 |
|